CD8A and B cell deficiency: In a recent study [4], naïve CD8+ T cells were found increased in patients undergoing RTX treatment compared to patients with B cell deficiency from another origin, and correlated to a subsequent spike protein–specific CD8+ T cell responses after vaccination.